Granted
The Board granted the veteran's appeal to restore a 30 percent rating for scalp and facial actinic keratosis post fluorouracil treatment, effective September 27, 2022.
The deciding factor: The Board found that reexamination of the Veteran's service-connected actinic keratosis did not disclose improvement.
- Claimed conditions
- scalp and facial actinic keratosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- January 16, 2025
- Citation
- A25004113
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.